Latest Cancer Therapy & Research Center Stories
Over-the-counter anti-inflammatory drugs such as aspirin or ibuprofen could significantly lower breast cancer recurrence rates in overweight or obese women, according to new research appearing in Friday’s edition of the journal Cancer Research.
Hispanics are the fastest-growing demographic group in the United States, and they suffer from major health disparities, including higher rates of cancers of the cervix, stomach and liver.
CALGARY, Feb. 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
SCOTTSDALE, Ariz., Sept.
CALGARY, Sept. 8 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc.
CALGARY, June 20 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S.
Michael J. Wick, Ph.D., a recognized leader in the research of new anti-cancer drugs, has been named director of preclinical research at South Texas Accelerated Research Therapeutics (START). He will join the START team on Sept. 3. Dr.
Chris H. M. Takimoto, M.D., Ph.D., an internationally recognized leader in the development of new anti-cancer drugs, has been named director of pharmacology at South Texas Accelerated Research Therapeutics (START). Dr.
SAN ANTONIO, July 20 /PRNewswire/ -- The Cancer T
- A hairdresser.